4//SEC Filing
Singer Michael 4
Accession 0001453687-24-000067
CIK 0001453687other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 9:47 PM ET
Size
33.2 KB
Accession
0001453687-24-000067
Insider Transaction Report
Form 4
Singer Michael
Director
Transactions
- Exercise/Conversion
Common Stock
2024-04-08+110,151→ 119,754 total - Exercise/Conversion
Common Stock
2024-04-08+14,535→ 14,788 total(indirect: By Spouse) - Exercise/Conversion
Common Stock
2024-04-08+377,208→ 383,796 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2024-04-08+7,005→ 7,127 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2024-04-08+55,746→ 56,719 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2024-04-08+94,568→ 96,219 total(indirect: as custodian) - Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-04-08−11,316.263→ 0 total(indirect: By Trust)→ Common Stock (377,208 underlying) - Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-04-08−1,672.389→ 0 total(indirect: By Trust)→ Common Stock (55,746 underlying) - Exercise/Conversion
Common Stock
2024-04-08+94,568→ 96,219 total(indirect: as custodian) - Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-04-08−210.152→ 0 total(indirect: By Trust)→ Common Stock (7,005 underlying) - Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-04-08−436.066→ 0 total(indirect: By Spouse)→ Common Stock (14,535 underlying) - Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-04-08−2,837.052→ 0 total(indirect: as custodian)→ Common Stock (94,568 underlying) - Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-04-08−3,304.559→ 0 total→ Common Stock (110,151 underlying) - Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-04-08−2,837.052→ 0 total(indirect: as custodian)→ Common Stock (94,568 underlying)
Holdings
- 7,600
Stock Option (Right to Buy)
Exercise: $19.66Exp: 2034-01-01→ Common Stock (7,600 underlying)
Footnotes (9)
- [F1]On March 27, 2024, the issuer held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, the stockholders of the issuer approved a 1-for-30 reverse stock split (the "Reverse Stock Split") of the issuer's common stock ("Common Stock") and the conversion of the issuer's Series A Non-Voting Convertible Preferred Stock ("Series A Preferred Stock") into shares of Common Stock. On April 8, 2024, the conversion of the majority of the shares of Series A Preferred Stock occurred automatically (the "Automatic Conversion"). The remaining shares of Series A Preferred Stock remain subject to certain beneficial ownership limitations described in the issuer's filings with the Securities and Exchange Commission. At the time of the Automatic Conversion, all of the reporting person's shares of Series A Preferred Stock converted into shares of Common Stock.
- [F2]On April 4, 2024, the issuer effected the Reverse Stock Split. The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
- [F3]Shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of this trust.
- [F4]Shares are held in a trust for which the reporting person is a beneficiary. The reporting person is a trustee of this trust.
- [F5]Shares are held in a trust for which the reporting person is a beneficiary. The reporting person's spouse is a trustee of this trust.
- [F6]Shares are held by the reporting person's spouse.
- [F7]The shares are held for LS, the child of the reporting person, through a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA") for which the reporting person serves as custodian.
- [F8]The shares are held for SS, the child of the reporting person, through a custodial account established pursuant to the UTMA for which the reporting person serves as custodian.
- [F9]This award will vest in 36 equal monthly installments, so that it shall be fully vested on the third anniversary of the date of grant.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0002000122
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 9:47 PM ET
- Size
- 33.2 KB